SCHEMBL22731971

SCHEMBL22731971

NC(=O)c1cnccc1N1CCN(CCN2CCOCC2)C(=O)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.47
PARP2 Q9UGN5 2/20 0.47
GAA P10253 1/20 0.39
ACHE P22303 1/20 0.38
DPP4 P27487 1/20 0.38
PRMT5 O14744 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37
BLM P54132 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CASR P41180 2/20 0.36
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL353775 0.79 SIRT3 (0.46) SMN1; SMN2NPC1MAPTHTTL3MBTL1
SCHEMBL22717662 0.73 POLQ (0.48) ALDH1A1
SCHEMBL31005773 0.71 CYP3A4 (0.52) GAANPC1LMNAMAPTKDM4E
SCHEMBL4708254 0.71 GAA (0.51) GAASMN1; SMN2MAPTHTTKDM4E
SCHEMBL883907 0.69 CDC7 (0.58) SMN1; SMN2NPC1MAPTHTTKDM4E
SCHEMBL3554851 0.69 CDC7 (0.48) SMN1; SMN2NPC1MAPTHTTRAB9A
SCHEMBL3627591 0.68 NPC1 (0.61) GAASMN1; SMN2NPC1MAPTHTT
SCHEMBL4907976 0.67 SMN1; SMN2 (0.50) GAASMN1; SMN2MAPTHTTL3MBTL1
Potassium SCHEMBL30402396 0.66 SMN1; SMN2 (0.49) GAASMN1; SMN2MAPTHTTL3MBTL1
SCHEMBL14663533 0.66 PIM1 (0.51) NPC1MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020243459-A1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES, INC. (US) 2020-12-03 WO disclosed